Watchmaker Genomics, a leader in high-performance NGS workflow solutions, today announced it will unveil two new technologies ...
Dr. Jay Bhaumik explains how AI embedded in dispensing, NLP, vision and anomaly detection helps reconcile data flows and ...
Mizuho Technology Conference 2026 June 9, 2026 2:35 PM EDTCompany ParticipantsPatrick Stokes - President & Chief ...
Across 76 weeks in obesity/overweight without type 2 diabetes, survodutide achieved up to 16.6% mean weight loss versus 3.2% ...
Buzz has been growing around the labor market for the past several months, but today's jobs report went the extra mile to ...
Mirum Pharmaceuticals Inc. (NASDAQ:MIRM) is one of the best high short interest stocks with highest upside potential.
Cary,NC - June 05, 2026 - PRESSADVANTAGE - USA Cabinet Store Cary, NC has implemented a dedicated regional designer ...
Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 9:20 AM EDTCompany ParticipantsBrian Scott ...
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat ...
MarketBeat on MSN
Arcturus Therapeutics highlights mRNA pipeline, CF data and vaccine expansion at Jefferies
Arcturus Therapeutics (NASDAQ:ARCT) President and CEO Joseph Payne outlined the company's messenger RNA programs, vaccine ...
President Donald Trump speaks as Israel's Prime Minister Benjamin Netanyahu listens during a news conference at Mar-a-Lago, ...
Researchers at Virginia Tech and the University of Utah found that a protein called PERM1 is restored in patients whose hearts recover after treatment with left ventricular assist devices, or LVADs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results